PLAY PODCASTS
Contemporary Management of HIV 2021: Frontiers in HIV Prevention, Part 2—Audio Recap
Episode 59

Contemporary Management of HIV 2021: Frontiers in HIV Prevention, Part 2—Audio Recap

Are you abreast of what is in the pipeline for HIV prevention? Listen to expert discussion by Joseph J. Eron, Jr., MD, on 4 investigational agents for HIV prevention.

Decera Clinical Education Infectious Disease Podcast · Joseph J Eron Jr MD

June 30, 202115m 39s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Listen to expert insights from Joseph J. Eron, Jr., MD, on exciting data about investigational agents (dapivirine ring, islatravir, lenacapavir, broadly neutralizing antibodies) for next-generation HIV prevention.

Joseph J. Eron, Jr., MD
Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Link to full program:
https://bit.ly/3ux6FF8


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

islatravirimplantvaginal ringnrttiaspireend the hiv epidemicringmtn-025/hope olenucleoside reverse transcriptase translocation inhibitorlenacapviripm 032/dream oleprepadolescentselective hiv-1 capsid inhibitorbroadly neutralizing antibodiesdreamipm 027bnabsdapivirinehopepwhivon-demand preplong-acting injectablemtn-020hivpwh